April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Tissue-based caldesmon silencing by naked siRNA increases F-actin in the human trabecular meshwork
Author Affiliations & Notes
  • Jose Miguel Gonzalez
    Ophthalmology, University of Southern California, Los Angeles, CA
  • James C H Tan
    Ophthalmology, University of Southern California, Los Angeles, CA
  • Footnotes
    Commercial Relationships Jose Gonzalez, None; James Tan, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5653. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jose Miguel Gonzalez, James C H Tan; Tissue-based caldesmon silencing by naked siRNA increases F-actin in the human trabecular meshwork. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5653. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Caldesmon overexpression downregulates actin fiber formation in human trabecular meshwork (TM) cells and increases outflow facility in cultured anterior segments. We tested the hypotheses that (1) caldesmon RNAi appreciably inhibits TM caldesmon expression, (2) and upregulates filamentous actin (F-actin) in situ.

Methods: Human donor corneoscleral tissues containing the intact TM were sectioned and incubated with Accell On-Target Plus siRNA for human Caldesmon (CALD-1) or a non-targeting control construct in siRNA delivery buffer (Life Technologies) for 3-5 days at 37°C and 8% CO2 then fixed with 4% paraformaldehyde, permeabilized with Triton X-100, and labeled with Hoechst 33342 and Alexa 568-conjugated phalloidin (Life Technologies) or anti-caldesmon antibodies (Abcam) and Alexa 568-conjugated secondaries. Tissues were imaged by 2-photon microscopy (TPM) using 800-850nm pulsed laser excitation and specific filters: 500-550nm bandpass (green; nuclei and structural autofluorescence) and 610-680nm (red; F-actin and caldesmon). Tissue viability was assessed by calcein AM and propidium iodide (PI) intravital co-labeling in situ.

Results: 1μM naked siRNA silencing of caldesmon reduced caldesmon immunolabeling in the human TM by 53.9±38.9% (p=0.03; n=5) relative to non-targeting control tissue. In situ redistribution of F-actin occurred following caldesmon RNAi as evidenced by enhanced F-actin cortical localization and a more prominent actin network relative to controls. F-actin fluorescence levels were increased by 61.0±46.8% with siRNA treatment (p=0.07; n=3). Structural matrix organization of collagen and elastin (via autofluorescence), cell counts, and viability were unchanged after caldesmon RNAi. 86.1% of cells were viable in siRNA-treated tissue compared with 85.8% in non-targeting controls.

Conclusions: Tissue-based caldesmon RNAi resulted in lower caldesmon expression, a redistribution of F-actin, and a more prominent actin network in the human TM. The TM actin reorganization represents increased actin polymerization and actomyosin contractility that is expected to affect aqueous outflow dynamics. We are now conducting in vivo studies to determine the effect of caldesmon RNAi on live animal outflow facility.

Keywords: 735 trabecular meshwork • 633 outflow: trabecular meshwork • 493 cytoskeleton  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×